CYH لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

03
السعر $2.72
القيمة السوقية (الربع الأخير) $384M
P/E (سنوي حالي) 1.5
ربح السهم (سنوي حالي) $1.86
الإيرادات (سنوي حالي) $11.98B
ROE (سنوي حالي) -16.7%
D/E الدين/حقوق الملكية (الربع الأخير) -6.9
نطاق 52 أسبوعًا $2–$4

CYH مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

04
نطاق
أشرطة

تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.

تجزئة الأسهم 1
تاريخ الاستحقاق تقسيم النوع
22 إبريل، 2016 121-for-100 أمامي

حول Community Health Systems, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

قطاعHealth Care صناعةHealth Care موظفون44000 بلدUS

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

06
الإيرادات$12.48B
2016-12-31 → 2025-12-31
ربح السهم$3.77
2016-12-31 → 2025-12-31
التدفق النقدي الحر$208M
2016-12-31 → 2025-12-31
هامش صافي2.1%
2018-12-31 → 2025-12-31
التقييم والنسب 07–12

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس اتجاه 5 سنوات CYH متوسط 5 سنوات متوسط الأقران الحكم
P/E (سنوي حالي) 1.5متوسط 5 سنوات ≈3.4 ≈3.4 15.5 مقوّم بأقل من قيمته
السعر/المبيعات (سنوي حالي) 0.0متوسط 5 سنوات ≈0.1 ≈0.1 1.2 مقوّم بأقل من قيمته
السعر / القيمة الدفترية (الربع الأخير) -0.3متوسط 5 سنوات ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.1متوسط 5 سنوات ≈13.1 ≈13.1 10.6 مقوّم بأقل من قيمته
السعر / التدفق النقدي الحر (سنوي حالي) -2.1متوسط 5 سنوات ≈-0.8 ≈-0.8 · ·
السعر / التدفق النقدي (سنوي حالي) 3.0متوسط 5 سنوات ≈-1.6 ≈-1.6 6.5 مقوّم بأقل من قيمته
EV / Revenue (القيمة المؤسسية / الإيرادات) 0.8متوسط 5 سنوات ≈1.0 ≈1.0 · ·
EV / FCF (القيمة المؤسسية / التدفق النقدي الحر) 50.5متوسط 5 سنوات ≈-4.9 ≈-4.9 · ·

يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.

القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط

التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات

13
تاريخ الاستحقاقالمبلغالعملةالعائد
ديسمبر 13, 2012$0,21USD≈0.84%

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

14
متوسط المفاجأة 37.9%
التقرير القادم أكتوبر 21, 2026
الفترةتقريرEPS ActualEPS المتوقعالمفاجأة
30 يونيو، 2026 يوليو 21, 2026 $-0.19 $-0.06 -201.1%
31 مارس، 2026 $-0.48 $-0.10 -387.3%
31 ديسمبر، 2025 $-0.01 $-0.10 90.5%
30 سبتمبر، 2025 $1.27 $-0.25 610.5%
30 يونيو، 2025 $-0.05 $-0.11 52.6%
31 مارس، 2025 $-0.03 $-0.08 62.6%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

15
قائمة الدخل 13
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
الميزانية العمومية 26
المقياس اتجاه 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
التدفق النقدي 13
المقياس اتجاه 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
الربحية 7
المقياس اتجاه 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
السيولة والملاءة 4
المقياس اتجاه 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
الكفاءة 2
المقياس اتجاه 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
لكل سهم 5
المقياس اتجاه 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
معدلات النمو 9
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
التقييم (آخر 12 شهرًا) 13
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

16
المقياس 2025-12-312024-12-312023-12-312022-12-312021-12-31
الإيرادات $12.48B $12.63B $12.49B $12.21B $12.37B
هامش الربح التشغيلي % 11.9% 4.3% 7.7% 6.7% 11.3%
صافي الدخل $509M $-516M $-133M $46M $230M
EPS المخفف $3.77 $-3.90 $-1.02 $0.35 $1.76

الملاك المؤسسيون (13F) 196 مقدمي إقرار · $415.1M إجمالي · حتى تاريخ 30 سبتمبر، 2026

17

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

حائزون 196
القيمة المحتفظ بها $415.1M
مراكز جديدة 31
المراكز الخارجة 24
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
31 (+9 مقابل الربع السابق) 24 (+4 مقابل الربع السابق) 69 (+6 مقابل الربع السابق) 54 (-9 مقابل الربع السابق) +7.0M

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
CastleKnight Management LP $44704517 13384586 10,77% الأسهم
Apollo Management Holdings, L.P. $39610817 11859526 9,54% الأسهم
BlackRock, Inc. $36507995 10930538 8,79% الأسهم
VANGUARD GROUP INC $28605579 9168455 6,89% الأسهم
Eversept Partners, LP $26267680 7864575 6,33% الأسهم
NOMURA HOLDINGS INC $22388384 6703109 5,39% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $17668370 5289931 4,26% الأسهم
WHITEBOX ADVISORS LLC $12467362 3732743 3,00% الأسهم
GEODE CAPITAL MANAGEMENT, LLC $10582352 3167702 2,55% الأسهم
STATE STREET CORP $10226622 3061863 2,46% الأسهم
VANGUARD PORTFOLIO MANAGEMENT LLC $10082117 3018598 2,43% الأسهم
Saba Capital Management, L.P. $9626444 2882169 2,32% الأسهم
Owl Creek Asset Management, L.P. $8452277 2530622 2,04% الأسهم
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8176380 2448018 1,97% الأسهم
DIMENSIONAL FUND ADVISORS LP $7854253 2351460 1,89% الأسهم
D. E. Shaw & Co., Inc. $7829388 2344128 1,89% الأسهم
AQR CAPITAL MANAGEMENT LLC $7651362 2290827 1,84% الأسهم
TWO SIGMA INVESTMENTS, LP $7365822 2205336 1,77% الأسهم
Diameter Capital Partners LP $6138793 1837962 1,48% الأسهم
BANK OF AMERICA CORP /DE/ $5903847 1767619 1,42% الأسهم
GOLDMAN SACHS GROUP INC $5868073 1756908 1,41% الأسهم
TWO SIGMA ADVISERS, LP $5816476 1864255 1,40% الأسهم
CARRONADE CAPITAL MANAGEMENT, LP $5230000 1565847 1,26% الأسهم
Allianz Asset Management GmbH $5167919 1547281 1,24% الأسهم
MORGAN STANLEY $4800489 1437272 1,16% الأسهم
NORTHERN TRUST CORP $4681414 1401621 1,13% الأسهم
Silver Rock Financial LP $3674000 1100000 0,89% الأسهم
CITADEL ADVISORS LLC $3475360 1040527 0,84% الأسهم
Assenagon Asset Management S.A. $2788275 834813 0,67% الأسهم
VANGUARD FIDUCIARY TRUST CO $2642231 791087 0,64% الأسهم
Jefferies Financial Group Inc. $2481286 742900 0,60% الأسهم
Alta Fundamental Advisers LLC $2161411 647129 0,52% الأسهم
Bank of New York Mellon Corp $2122084 635354 0,51% الأسهم
MARSHALL WACE, LLP $1906575 570831 0,46% الأسهم
MILLENNIUM MANAGEMENT LLC $1701580 509455 0,41% الأسهم
ExodusPoint Capital Management, LP $1664603 498384 0,40% الأسهم
READYSTATE ASSET MANAGEMENT LP $1657729 496326 0,40% الأسهم
WOLVERINE ASSET MANAGEMENT LLC $1339674 401100 0,32% عقد خيار الشراء
Helix Partners Management LP $1336000 400000 0,32% الأسهم
Susquehanna Portfolio Strategies, LLC $1280940 383515 0,31% الأسهم
Voleon Capital Management LP $1247032 373363 0,30% الأسهم
Invesco Ltd. $1076599 322335 0,26% الأسهم
TUDOR INVESTMENT CORP ET AL $999388 299218 0,24% الأسهم
Pathstone Holdings, LLC $895621 268150 0,22% الأسهم
Prescott Group Capital Management, L.L.C. $863076 258406 0,21% الأسهم
UBS Group AG $851089 254817 0,21% الأسهم
MILLENNIUM MANAGEMENT LLC $835000 250000 0,20% عقد خيار البيع
FEDERATED HERMES, INC. $812599 243293 0,20% الأسهم
LPL Financial LLC $737239 220730 0,18% الأسهم
IEQ CAPITAL, LLC $657963 196995 0,16% الأسهم

عرض جميع الملاك المؤسسيين البالغ عددهم 196 →

الناشطون والمالكون بنسبة 5%+ 1 حيازة

18

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 إيداعات 11 مارس، 2021 · إيداع أولي · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

المطلعون على الشركة 56 من المطلعين · مسؤولون 29 · مديرون 23

19
مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Kevin J Hammons CEO 1 مارس، 2026 A 895545 0 0 $0
Tim Hingtgen CEO 1 مارس، 2025 A 1388781 0 0 $0
Jason K Johnson EVP & CFO 1 مارس، 2026 A 268439 0 0 $0
Thomas J Aaron EVP and CFO 7 ديسمبر، 2019 F 241515 0 0 $0
Larry W Cash President and CFO 1 مارس، 2017 A 568152 0 0 $0
Miguel S Benet President and CMO 1 مارس، 2025 D 47635 0 0 $0
Austen D Mason Regional President 1 مارس، 2025 A 142500 0 0 $0
Mark B Medley Regional President 1 مارس، 2025 A 128637 0 0 $0
Chad A Campbell Regional President 1 مارس، 2025 A 136815 0 0 $0
Charles J Cova Regional President 1 مارس، 2024 A 58701 0 0 $0
Lynn T Simon President and CMO 1 مارس، 2024 A 482657 0 0 $0
Beryl Ramsey Division President 1 مارس، 2019 A 62969 0 0 $0
Patton Paul Smith Division President 1 مارس، 2019 F 119017 0 0 $0
Iii John W Mcclellan Division President 1 مارس، 2017 A 41242 0 0 $0
Robert O Horrar Division President 1 مارس، 2017 A 68649 0 0 $0
Martin Bonick Division President 1 مارس، 2017 A 100458 0 0 $0
Michael T Portacci Division President 1 مارس، 2017 A 110156 0 0 $0
Thomas Daniel Miller Division President 1 مارس، 2016 A 112107 0 0 $0
David Lewis Miller President and COO 1 مارس، 2016 A 440840 0 0 $0
William S Hussey Division President 28 أكتوبر، 2015 M 121568 0 0 $0
Martin Dewayne Smith Division President 3 يونيو، 2015 M 94111 0 0 $0
Gary D Newsome Division President - Group Ops 25 أغسطس، 2008 M 118286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1 يونيو، 2026 A 30000 0 0 $0
Phillip A. Posey SVP & CAO 1 مارس، 2026 A 51736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1 مارس، 2026 A 287750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1 مارس، 2026 A 208290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1 مارس، 2017 F 243065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 فبراير، 2012 F 78379 0 0 $0
Martin G Schweinhart Senior Vice President 1 مارس، 2006 A 40354 0 0 $0
William Norris Jennings مدير 25 أغسطس، 2026 S 38468 0 1 $-118400
Ranga K Krishnan مدير 30 يونيو، 2026 M 170023 0 0 $0
Fawn D Lopez مدير 1 مارس، 2026 A · 0 0 $0
Ronald L Burgess JR مدير 1 مارس، 2026 A · 0 0 $0
Susan W Brooks مدير 1 مارس، 2026 A 108695 0 0 $0
Hubert James Williams مدير 1 مارس، 2026 A 211863 0 0 $0
Joseph Arthur Hastings مدير 1 مارس، 2026 A 0 0 0 $0
Elizabeth T Hirsch مدير 1 مارس، 2026 A 162059 0 0 $0
James S. Ely III مدير 1 مارس، 2026 A 412876 0 0 $0
John A Fry مدير 1 مارس، 2026 A 268966 0 0 $0
John A Clerico مدير 1 مارس، 2026 A 368763 0 0 $0
Michael Dinkins مدير 1 مارس، 2026 A 225882 0 0 $0
Wayne T Smith مدير 1 مارس، 2026 A 5217579 0 0 $0
Julia B North مدير 1 مارس، 2021 A 162056 0 0 $0
Mitchell H Watson JR مدير 16 مايو، 2017 M 22594 0 0 $0
Harvey Klein MD مدير 15 مارس، 2010 M 10383 0 0 $0
Dale F Frey مدير 31 مارس، 2008 A 20000 0 0 $0
Thomas H Lister مدير 21 سبتمبر، 2004 S 0 0 0 $0
Thodore Forstmann مدير 21 سبتمبر، 2004 S 0 0 0 $0
Sandra Horbach مدير 21 سبتمبر، 2004 S 0 0 0 $0
Robert J Dole مدير 6 مايو، 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP مالك 10% 21 سبتمبر، 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP مالك 10% 21 سبتمبر، 2004 S 0 0 0 $0
Winston Hutchins مالك 10% 21 سبتمبر، 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP مالك 10% 21 سبتمبر، 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P مالك 10% 21 سبتمبر، 2004 S 0 0 0 $0
Benjamin C Fordham · 1 مارس، 2021 A 254608 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 25 صناديق مؤشرات متداولة

20

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
BSJR · Invesco Exchange-Traded Self-Indexe… 2,85% 24817000 2 أكتوبر، 2026 يومي
EBIT · Harbor ETF Trust 0,45% 19210 NS 31 يوليو، 2026 N-PORT
IWC · iShares Trust 0,09% 443690 SH 11 سبتمبر، 2026 يومي
IHF · iShares Trust 0,05% 223947 SH 11 سبتمبر، 2026 يومي
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113109 SH 19 أغسطس، 2026 يومي
NEAR · iShares U.S. ETF Trust 0,03% 1340000 SH 11 سبتمبر، 2026 يومي
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 221871 SH 2 أكتوبر، 2026 يومي
IWM · iShares Trust 0,01% 3425206 SH 11 سبتمبر، 2026 يومي
RSSL · Global X Funds 0,01% 62038 NS 31 يوليو، 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746733 SH 19 أغسطس، 2026 يومي
VHT · VANGUARD WORLD FUND 0,01% 349881 SH 19 أغسطس، 2026 يومي
DFAS · Dimensional ETF Trust 0,01% 289348 NS 31 يوليو، 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202789 NS 31 يوليو، 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33838 NS 31 يوليو، 2026 N-PORT
ITOT · iShares Trust 0,00% 203848 SH 11 سبتمبر، 2026 يومي
IWV · iShares Trust 0,00% 42177 SH 3 سبتمبر، 2026 يومي
DCOR · Dimensional ETF Trust 0,00% 6184 NS 31 يوليو، 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31135 NS 31 يوليو، 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1347195 SH 19 أغسطس، 2026 يومي
VTI · VANGUARD INDEX FUNDS 0,00% 3813888 SH 19 أغسطس، 2026 يومي
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9817 SH 19 أغسطس، 2026 يومي
DFSU · Dimensional ETF Trust 0,00% 24 NS 31 يوليو، 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 يوليو، 2026 يومي
VPLS · VANGUARD MALVERN FUNDS · · 15 يوليو، 2026 يومي
IWN · iShares Trust · 1223127 SH 11 سبتمبر، 2026 يومي

CYH توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

21
تصنيف · 16 محللين احتفاظ
السعر المستهدف الوسيط $3.12 +14,9%
1 6,2% شراء قوي
1 6,2% شراء
6 37,5% احتفاظ
7 43,8% بيع
1 6,2% بيع قوي

السعر المستهدف لمدة 12 شهرًا

8 محللين · 2026-10-01

السعر المستهدف المتوسط $3.16 +16,0%

الآن السعر الحالي $2.72
منخفض$2.00 المتوسط$3.16 مرتفع$4.00

مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع

22

أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.

الرمز القيمة السوقية P/E الإيرادات سنويًا هامش الربح الصافي ROE هامش الربح الإجمالي
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

آخر الأخبار أحدث العناوين التي تذكر هذه الشركة

23

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

26

اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

المصدر: إيداع SEC 10-Q بتاريخ يوليو 23, 2026